City
Epaper

Black Fungus: India receives 50,000 vials of Amphotericin-B from US Pharma companies

By ANI | Updated: May 28, 2021 17:10 IST

India on Friday received 50,000 vials of Amphotericin-B, the drug used for the treatment of Mucormycosis, commonly known as Black Fungus, at Mumbai Airport.

Open in App

India on Friday received 50,000 vials of Amphotericin-B, the drug used for the treatment of Mucormycosis, commonly known as Black Fungus, at Mumbai Airport.

Mucormycosis has wreaked havoc across the country, especially in Covid-19 patients who have been administered heavy doses of steroids to treat the infection.

Mansukh Mandaviya, Minister of State for Chemicals and Fertilizers said that the ministry is putting in a lot of effort to meet the requirements of the drug in the country, after the increase in the cases of Black Fungus in the country.

The minister tweeted, "50,000 vials of #AmphotericinB arrives at Mumbai Airport. We are putting in a lot of efforts to meet its requirement in the country. I am thankful to @GileadSciences and @MylanNews for their outstanding support in India's fight against COVID-19".

Prime Minister Narendra Modi has instructed all concerned officials to arrange the drug from anywhere in the world on a war footing.

"The PM had instructed officials to get this drug from anywhere it is available in the world. Indian missions across the world have been involved in securing supplies of this drug. It has been achieved with help of Gilead Sciences in USA," the sources said.

On May 21, Delhi had a total of 200 cases of Black Fungus, the number of the infection witnessed a steep rise and reached 620 on May 26. After which the capital city declared Black Fungus as an epidemic disease.

Madhya Pradesh, Rajasthan, Uttarakhand, Tamil Nadu, and Bihar are other states to have declared the infection as an epidemic disease under the Epidemic Disease Act 1897.

The Delhi High Court on Thursday asked the Central government to consider a complete waiver of import duties of the drug Amphotericin B, used to treat Mucormycosis, for a limited period till the scarcity of drug is resolved in the country.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Advances in Applied MicrobiologydelhimumbaiNarendra ModiGilead sciencesGilead`delhiGilead sciences incDelhi capitalSouth delhi district administration
Open in App

Related Stories

MumbaiChinchpokli Cha Chintamani Aagman Sohala 2025 Date: Arrival Time of Mumbai’s Most Awaited Ganesh Idol for Ganeshotsav Announced

MumbaiIIT Bombay’s Eureka! 2025: The Biggest Opportunity for All the Startup Founders

MumbaiDevendra Fadnavis Disagrees with Abrupt Closure of Mumbai’s Kabutarkhanas, Urges Regulated Measures to Mitigate Health Risks

NationalAmit Shah Sets Record as Longest-Serving Home Minister, Surpassing LK Advani

NationalCity Living Redefined: The Rise of Used Cars in Delhi’s Lifestyle Trends

National Realted Stories

NationalArunachal Guv congratulates Kabak Yano for scaling Mount Kilimanjaro

NationalAndhra Pradesh’s NDA govt extends Rs 1 lakh aid for Hajj pilgrims

NationalFPOs need to step up to play crucial role in food processing and increasing farmers income, says MP CM

NationalNo change in status of tribal belts and blocks in Assam: CM Sarma

NationalOdisha: Health Minister urges centre to expedite LoP for MBBS admissions